FluGen May Seek Funding from $12M Gates-Backed Flu Vaccine Challenge

Last week, the Bill and Melinda Gates Foundation announced that it plans to provide researchers with up to $12 million in funding as part of a new initiative to support the development of a universal influenza vaccine.

However, the Gates Foundation’s commitment to improving on the status quo in flu vaccines underscores the threat a major flu outbreak would pose to public health, says Paul Radspinner. He’s the co-founder and CEO of FluGen, a Madison, WI-based startup that develops flu vaccine candidates designed to protect against multiple strains of the disease.